Northern International Equity Fund (NOIGX) is a Foreign Large Value fund with $172.96 Million in assets. The fund allocates 14.56% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Novartis AG CHF0.49 at 2.05% of total assets. This is followed by Shell PLC ORD EUR0.07 (1.80%) and Novo Nordisk A/S SER'B'DKK0.1 (1.48%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Novartis AG CHF0.49 | 2.05% | - | - |
| Shell PLC ORD EUR0.07 | 1.80% | - | - |
| Novo Nordisk A/S SER'B'DKK0.1 | 1.48% | - | - |
| ABB Ltd. CHF0.12 | 1.41% | - | - |
| Roche Holdings AG GENUSSCHEINE NPV | 1.40% | - | - |
| Canadian Natural Resources Limited COM NPV | 1.36% | - | - |
| ITOCHU Corp. NPV | 1.34% | - | - |
| GSK plc ORD GBP0.3125 | 1.26% | - | - |
| Manulife Financial Corporation COM NPV | 1.21% | - | - |
| ANZ Group Holdings Ltd. NPV | 1.25% | - | - |
| Roche Holding AG GENUSSCHEINE NPV | 1.77% | - | - |
| Sumitomo Mitsui Financial Group Inc. NPV | 1.45% | - | - |
| Deutsche Telekom AG NPV | 1.37% | - | - |
| Banco Bilbao Vizcaya Argentaria SA EUR0.49 | 1.36% | - | - |
| Barclays PLC ORD GBP0.25 | 1.26% | - | - |
| Investor AB SER'B'NPV | 1.24% | - | - |
| NOVARTIS AG CHF0.49 | 2.06% | - | - |
| ROCHE HOLDINGS AG GENUSSC | 1.98% | - | - |
| SHELL PLC | 1.49% | - | - |
| BANCO BILBAO VIZCAYA ARGE | 1.48% | - | - |
| GSK PLC | 1.43% | - | - |
| ASML HLDG. NV | 1.38% | - | - |
| UNICREDIT SPA | 1.34% | - | - |
| MITSUBISHI CORP | 1.30% | - | - |
| BARCLAYS PLC | 1.27% | - | - |
| TOKYO ELECTRON LTD | 1.24% | - | - |